- Home
- CTOS vs BHVN Comparison
CTOS vs BHVN Comparison
Compare CTOS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- BHVN
- Stock Information
- Founded
- CTOS 1988
- BHVN 2013
- Country
- CTOS United States
- BHVN United States
- Employees
- CTOS N/A
- BHVN N/A
- Industry
- CTOS Diversified Commercial Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CTOS Consumer Discretionary
- BHVN Health Care
- Exchange
- CTOS Nasdaq
- BHVN Nasdaq
- Market Cap
- CTOS 1.4B
- BHVN 1.5B
- IPO Year
- CTOS N/A
- BHVN 2017
- Fundamental
- Price
- CTOS $5.80
- BHVN $14.91
- Analyst Decision
- CTOS Buy
- BHVN Strong Buy
- Analyst Count
- CTOS 3
- BHVN 15
- Target Price
- CTOS $6.83
- BHVN $53.86
- AVG Volume (30 Days)
- CTOS 688.6K
- BHVN 2.1M
- Earning Date
- CTOS 10-29-2025
- BHVN 11-11-2025
- Dividend Yield
- CTOS N/A
- BHVN N/A
- EPS Growth
- CTOS N/A
- BHVN N/A
- EPS
- CTOS N/A
- BHVN N/A
- Revenue
- CTOS $1,901,675,000.00
- BHVN N/A
- Revenue This Year
- CTOS $13.58
- BHVN N/A
- Revenue Next Year
- CTOS $5.18
- BHVN $2,195.07
- P/E Ratio
- CTOS N/A
- BHVN N/A
- Revenue Growth
- CTOS 6.21
- BHVN N/A
- 52 Week Low
- CTOS $3.03
- BHVN $12.79
- 52 Week High
- CTOS $6.64
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CTOS 48.16
- BHVN 51.20
- Support Level
- CTOS $5.63
- BHVN $13.41
- Resistance Level
- CTOS $5.92
- BHVN $14.23
- Average True Range (ATR)
- CTOS 0.20
- BHVN 0.86
- MACD
- CTOS -0.04
- BHVN -0.16
- Stochastic Oscillator
- CTOS 32.69
- BHVN 38.15
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.